| Basics |
Retractable Technologies, Inc
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. It offers 1mL tuberculin; allergy antigen VanishPoint syringes.
|
| IPO Date: |
May 4, 2001 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$20.54M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 3.47%
|
| Avg Daily Range (30 D): |
$0.02 | 2.76%
|
| Avg Daily Range (90 D): |
$0.02 | 2.98%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.1M |
| Avg Daily Volume (30 D): |
.04M |
| Avg Daily Volume (90 D): |
.04M |
| Trade Size |
| Avg Trade Size (Sh.): |
213 |
| Avg Trade Size (Sh.) (30 D): |
401 |
| Avg Trade Size (Sh.) (90 D): |
369 |
| Institutional Trades |
| Total Inst.Trades: |
38 |
| Avg Inst. Trade: |
$1.39M |
| Avg Inst. Trade (30 D): |
$3.19M |
| Avg Inst. Trade (90 D): |
$3.19M |
| Avg Inst. Trade Volume: |
.21M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.02M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
304.39K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.77
|
$-.35
|
$.13
|
|
Diluted EPS
|
$-.77
|
$-.35
|
$.13
|
|
Revenue
|
$ 33.75M
|
$ 8.3M
|
$ 9.07M
|
|
Gross Profit
|
$ -2.93M
|
$ M
|
$ -2.49M
|
|
Net Income / Loss
|
$ -22.82M
|
$ -10.5M
|
$ 3.77M
|
|
Operating Income / Loss
|
$ -22.8M
|
$ -4.68M
|
$ -7.22M
|
|
Cost of Revenue
|
$ 36.68M
|
$ 8.3M
|
$ 11.57M
|
|
Net Cash Flow
|
$ -6.63M
|
$ -.85M
|
$ .32M
|
|
PE Ratio
|
|
|
|
|
